Zacks Research Cuts Earnings Estimates for Acadia Healthcare

Acadia Healthcare Company, Inc. (NASDAQ:ACHC - Free Report) - Zacks Research lowered their Q3 2026 earnings per share estimates for Acadia Healthcare in a research note issued on Wednesday, July 16th. Zacks Research analyst R. Sipani now expects that the company will earn $0.92 per share for the quarter, down from their previous estimate of $0.93. The consensus estimate for Acadia Healthcare's current full-year earnings is $3.38 per share.

Acadia Healthcare (NASDAQ:ACHC - Get Free Report) last issued its quarterly earnings data on Monday, May 12th. The company reported $0.40 earnings per share for the quarter, topping the consensus estimate of $0.35 by $0.05. The company had revenue of $770.51 million during the quarter, compared to analyst estimates of $769.90 million. Acadia Healthcare had a return on equity of 8.72% and a net margin of 5.94%. The firm's revenue for the quarter was up .3% compared to the same quarter last year. During the same period in the prior year, the business posted $0.84 earnings per share.

Several other brokerages have also weighed in on ACHC. Stephens upgraded Acadia Healthcare to a "hold" rating in a research report on Monday, June 2nd. Mizuho lowered their price target on Acadia Healthcare from $37.00 to $32.00 and set a "neutral" rating for the company in a research report on Wednesday, May 14th. KeyCorp lowered their price target on Acadia Healthcare from $65.00 to $55.00 and set an "overweight" rating for the company in a research report on Wednesday, May 14th. Wall Street Zen upgraded Acadia Healthcare from a "sell" rating to a "hold" rating in a research report on Thursday, May 22nd. Finally, Barclays lowered their price target on Acadia Healthcare from $35.00 to $28.00 and set an "equal weight" rating for the company in a research report on Wednesday, May 14th. Five equities research analysts have rated the stock with a hold rating and six have given a buy rating to the company. According to data from MarketBeat, the company has a consensus rating of "Moderate Buy" and an average price target of $47.94.

Acadia Healthcare Trading Down 5.4%

Acadia Healthcare stock traded down $1.23 during mid-day trading on Monday, hitting $21.74. The company's stock had a trading volume of 1,633,056 shares, compared to its average volume of 1,724,767. The firm has a market capitalization of $2.00 billion, a PE ratio of 10.71, a price-to-earnings-growth ratio of 4.38 and a beta of 0.93. Acadia Healthcare has a 1 year low of $20.35 and a 1 year high of $82.40. The company has a current ratio of 1.35, a quick ratio of 1.35 and a debt-to-equity ratio of 0.72. The stock's fifty day moving average is $22.75 and its two-hundred day moving average is $29.64.

Institutional Trading of Acadia Healthcare

Several hedge funds have recently modified their holdings of the stock. Inspire Investing LLC raised its stake in shares of Acadia Healthcare by 51.5% in the second quarter. Inspire Investing LLC now owns 16,927 shares of the company's stock valued at $384,000 after acquiring an additional 5,753 shares in the last quarter. Aberdeen Group plc raised its stake in shares of Acadia Healthcare by 220.8% in the second quarter. Aberdeen Group plc now owns 348,117 shares of the company's stock valued at $7,899,000 after acquiring an additional 239,595 shares in the last quarter. Truist Financial Corp raised its stake in shares of Acadia Healthcare by 85.6% in the second quarter. Truist Financial Corp now owns 82,741 shares of the company's stock valued at $1,877,000 after acquiring an additional 38,167 shares in the last quarter. Janney Montgomery Scott LLC acquired a new stake in shares of Acadia Healthcare in the second quarter valued at $479,000. Finally, Signaturefd LLC raised its stake in Acadia Healthcare by 1,451.7% in the second quarter. Signaturefd LLC now owns 5,043 shares of the company's stock valued at $114,000 after buying an additional 4,718 shares in the last quarter.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.